Production Of Nicosan To Restart, Competition Of SCD Drugs Increasing

BMI View: Specific health needs in emerging markets, which had previously been neglected because of the need to maintain shareholder value, may become commercially viable as average pharmaceutical expenditure increases. Competition for sickle cell disease (SCD) drugs is beginning to intensify as production of Nicosan (ethanol/water extract of Piper guineense seeds, Pterocarpus osum stem, Eugenia caryophyllus fruit and Sorghum bicolor leaves) resumes in Nigeria, and other drugs enter clinical

To read the full article, please choose one of the following options: